VAIA
CCXI

Virtus Alternative Investment Advisers’s ChemoCentryx, Inc. CCXI Stock Holding History

Virtus Alternative Investment Advisers’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-106
Closed -$7K – 256
2020
Q4 		$7K Sell
106
-103
-49% -$5.9K 0.1% 165
2020
Q3 		$11K Buy
+209
New +$11.3K 0.2% 239

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Virtus Alternative Investment Advisers's CCXI Position: Q1 2021 in Review

Virtus Alternative Investment Advisers sold out of ChemoCentryx, Inc. (CCXI) in Q1 2021, closing a stake of 106 shares — an estimated $7K sold.

Virtus Alternative Investment Advisers first reported a position in CCXI in Q3 2020 and held it in 2 quarters. The position peaked at $11K in Q3 2020. 183 funds tracked by Wall St. Rank hold CCXI as of Q1 2021.

  • Virtus Alternative Investment Advisers reported no remaining ChemoCentryx, Inc. position as of Q1 2021 after selling out during the quarter.
  • Virtus Alternative Investment Advisers sold 106 ChemoCentryx, Inc. shares in Q1 2021, an estimated $7K.
  • Virtus Alternative Investment Advisers first reported a position in ChemoCentryx, Inc. in Q3 2020 and held it in 2 quarters.
  • Virtus Alternative Investment Advisers's ChemoCentryx, Inc. position peaked at $11K in Q3 2020.
  • 183 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q1 2021.

Based on Virtus Alternative Investment Advisers's 13F filing for Q1 2021.